ADAPALENE PRODUCTS MARKET ANALYSIS

The global adapalene products market is expected to witness significant growth over the forecast period, owing to increasing approval of adapalene products by the regulatory authorities such as U.S. Food Drug and Administration (FDA). For instance, in 2016, Differin gel 0.1% (Galderma Laboratories company product) was approved by U.S Food Drug and Administration (FDA) for over the counter (OCT) treatment of acne. Differin gel 0.1% is approved for patients who are 12 years and above.

Furthermore, rising prevalence of skin related problems such as acne among populace is another factor that is expected to drive global adapalene products market growth. For instance, according to the National Center for Biotechnology Information (NCBI) 2019 report, out of 100 about 15 to 30 teenagers are suffering from the moderate to severe acne and is mostly found in females, in comparison to male.

Moreover, availability of less expensive adapalene is the factor that is expected to boost the global adapalene products market growth over the forecast period. For instance, for a 45 g tube, average cost of the prescribed only branded Differin gel 0.1% is US$ 300, while the average cost of the prescribed only generic adapalene 0.1% gel is US$ 150.